Valuation: West Pharmaceutical Services, Inc.

Market Cap 26.96B 497B 24.06B 22.36B 20.34B 38.27B 2,553B 38.96B 269B 105B 1,332B 101B 99.01B 4,263B P/E 2026 *
44.7x
P/E 2027 * 38.8x
Enterprise Value 26.45B 488B 23.61B 21.94B 19.96B 37.55B 2,505B 38.23B 264B 103B 1,307B 99.27B 97.16B 4,183B EV / Sales 2026 *
7.84x
EV / Sales 2027 * 7.24x
Free-Float
92.88%
Yield 2026 *
0.24%
Yield 2027 * 0.25%
1 year 5,112.51
Extreme 5112.51
5,112.51
3 years 4,000
Extreme 4000
7,104.95
5 years 4,000
Extreme 4000
9,649
10 years 4,000
Extreme 4000
9,649
Manager TitleAgeSince
Chief Executive Officer 52 30/08/2026
Director of Finance/CFO 57 03/08/2025
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Director/Board Member 65 31/01/2011
Director/Board Member 69 06/03/2011
Director/Board Member 56 11/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
+15.28%-.--% - - 26.37B
+2.29%+6.28%-19.13%+15.20% 178B
+1.29%+8.77%+0.12%+32.64% 121B
+4.12%+5.87%-20.70%+13.71% 108B
+0.41%+3.99%-44.97%-9.38% 75.7B
+1.56%+6.24%+6.82%+80.66% 64.15B
+1.70%+1.36%+14.78%+66.96% 53.49B
+2.58%+6.02%+3.74%-25.10% 51.45B
+3.43%+6.63%-14.39%+28.39% 41.68B
+5.08%+3.91%+34.09%+15.12% 31.5B
Average +3.78%+5.39%-4.40%+24.24% 80.52B
Weighted average by Cap. +2.76%+5.88%-9.85%+22.82%

Financials

2026 *2027 *
Net sales 3.38B 62.28B 3.01B 2.8B 2.55B 4.79B 320B 4.88B 33.63B 13.16B 167B 12.67B 12.4B 534B 3.59B 66.2B 3.2B 2.98B 2.71B 5.09B 340B 5.18B 35.75B 13.99B 177B 13.46B 13.18B 567B
Net income 619M 11.42B 552M 513M 467M 878M 58.6B 894M 6.17B 2.41B 30.58B 2.32B 2.27B 97.84B 710M 13.1B 633M 589M 535M 1.01B 67.21B 1.03B 7.07B 2.77B 35.07B 2.66B 2.61B 112B
Net Debt -503M -9.29B -449M -418M -380M -714M -47.67B -727M -5.02B -1.96B -24.87B -1.89B -1.85B -79.58B -973M -17.96B -869M -808M -735M -1.38B -92.2B -1.41B -9.7B -3.8B -48.11B -3.65B -3.58B -154B
Projected Income Statement - Annual - West Pharmaceutical Services, Inc.
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
383.02USD
Average target price
412.88USD
Spread / Average Target
+7.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - West Pharmaceutical Services, Inc.